Philogen Logo

Philogen

PHIL | XMIL

Overview

Corporate Details

ISIN(s):
IT0005373789 (+1 more)
LEI:
81560009EA1577917768
Country:
Italy
Address:
PIAZZA LA LIZZA, 7, 53100 SIENA
Sector:
Health Care
Industry:
Biotechnology

Description

Founded in 1996, Philogen is an Italian-Swiss biotechnology company engaged in the discovery and development of biopharmaceutical products for the treatment of life-threatening conditions. Philogen Group mainly discovers and develops targeted anti-cancer drugs, exploiting high-affinity ligands for tumor markers. These ligands – namely human monoclonal antibodies or small molecules – are identified through Antibody Phage Display Libraries and DNA-Encoded Chemical Libraries technologies. The main therapeutic strategy of the Group for the treatment of these diseases is the so-called “tumor targeting”.

Social Media

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-06-30 17:04
Transaction in Own Shares
2025 06 30 - CS settimanale acquisto azioni proprie
Italian 181.7 KB
2025-06-25 12:29
Regulatory News Service
Philogen Provides Update on Marketing Authorization Application for Nidlegy™ in…
English 180.5 KB
2025-06-11 01:34
Regulatory News Service
Press Release Licenza OncoACP3 (Price Sensitive)
Italian 225.0 KB
2025-06-03 13:40
Transaction in Own Shares
2025 06 03 - CS settimanale acquisto azioni proprie
Italian 144.1 KB
2025-05-26 17:46
Share Issue/Capital Change
Statuto
Italian 261.6 KB
2025-05-26 17:24
AGM Report
Deposito del Verbale dell'Assemblea degli Azionisti
Italian 131.0 KB
2025-05-26 17:22
General Meeting Notice
Verbale dei lavori dell'Assemblea Ordinaria e Straordinaria degli Azionisti
Italian 30.4 MB
2025-05-26 15:09
Transaction in Own Shares
2025 05 26 - CS settimanale acquisto azioni proprie
Italian 147.5 KB
2025-05-19 12:24
Transaction in Own Shares
2025 05 19 - CS settimanale acquisto azioni proprie
Italian 130.7 KB
2025-05-12 15:04
Transaction in Own Shares
2025 05 12 - CS settimanale acquisto azioni proprie
Italian 141.2 KB
2025-05-07 10:30
Transaction in Own Shares
Allegato 3F
Italian 27.5 KB
2025-05-06 18:56
Interim Report
Il Consiglio di Amministrazione approva la posizione finanziaria netta relativa…
Italian 259.8 KB
2025-04-29 18:05
AGM Report
Comunicato stampa Assemblea 29 aprile 2025
Italian 209.6 KB
2025-04-14 12:55
Directors' Dealings
Allegato 3F
Italian 28.1 KB
2025-04-14 12:35
Transaction in Own Shares
2025 04 14 - CS settimanale acquisto azioni proprie
English 441.8 KB

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
1NKEMIA Logo 1NKEMIA Spain IKM
2cureX AB Logo 2cureX AB Sweden 2CUREX
4SC AG Logo 4SC AG Germany VSC
Abera Bioscience AB Logo Abera Bioscience AB Sweden ABERA
ABIONYX Pharma Logo ABIONYX Pharma France ABNX
Abliva Logo Abliva Sweden ABLI
AB Science Logo AB Science France AB
Acticor Biotech Logo Acticor Biotech France ALACT
Active Biotech Logo Active Biotech Sweden ACTI
AcuCort AB Logo AcuCort AB Sweden ACUC